Odyssey Health, Inc. (ODYY) shareholders
Close on Oct 19, 2026Market cap $746.34KP/E –Yield –
Ownership
Who owns Odyssey Health's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Lutz Jonathan D | 7,239,595 | 7.30% | 13G (passive) amendment | Nov 21, 2025 |
| Odyssey Health, Inc. | 511,308 | 16.60% | 13D (active) | Dec 28, 2023 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John P. Gandolfo – | Jan 10, 2024 | Award | +1,500,000 | $0.09 | $135.00K | 1,738,792 |
| J. Michael Redmond President & CEO, Director | Sep 2, 2022 | Gift | −1,500,000 | $0.16 | $240.00K | 8,500,000 |
| Jacob Ph.D Vanlandingham – | Jun 10, 2022 | Award | +1,000,000 | $0.23 | $230.00K | 9,660,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Odyssey Health's stock actually held short. Settlement fails (shares not delivered on time) peaked at 45,555 shares on Sep 8, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Odyssey Health, Inc. Stockholder | Jun 13, 2025 | 17,044 | $79.94K | Jun 10, 2025 | Asset Purchase Agreement |
See a number that looks wrong?